Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orsini-selected-as-exclusive-specialty-pharmacy-partner-for-ionis-dawnzera-donidalorsen-302536942.html
23 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/crowded-hae-market-steps-ionis-after-fda-nod-dawnzera
30 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250730350664/en/Ionis-reports-second-quarter-2025-financial-results-and-highlights-progress-on-key-programs
21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721310278/en/Phase-3-OASISplus-data-demonstrating-benefit-of-donidalorsen-for-HAE-patients-who-switched-from-other-prophylactics-published-in-JACI-In-Practice
16 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250716888547/en/Ionis-to-hold-second-quarter-2025-financial-results-webcast
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250625591486/en/Ionis-announces-Biogen-to-advance-salanersen-into-SMA-registrational-studies-based-on-positive-interim-Phase-1-results
ABOUT THIS PAGE
Ionis Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Nusinersen Sodium bulk offered by Ionis Pharmaceuticals